Dirk M Nettelbeck - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Dirk M Nettelbeck

Showing results (61-70 of 66) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 66 results.

Cancer Research|March 13, 2002

Treatment of ovarian cancer with a tropism modified oncolytic adenovirusGerd J Bauerschmitz, John T Lam, Anna Kanerva, et al.

Oncotarget|February 26, 2015

Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapyOtto Hemminki, Suvi Parviainen, Juuso Juhila, et al.

International Journal of Cancer|March 31, 2015

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humansSimona Bramante, Johanna K Kaufmann, Ville Veckman, et al.

Cancer Gene Therapy|March 16, 2004

Transcriptional targeting of tumors with a novel tumor-specific survivin promoterZeng B Zhu, Sharmila K Makhija, Baogen Lu, et al.

Human Gene Therapy|September 6, 2017

Virotherapy Research in Germany: From Engineering to TranslationGuy Ungerechts, Christine E Engeland, Christian J Buchholz, et al.

Viruses|August 28, 2021

Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical StudiesDirk M Nettelbeck, Mathias F Leber, Jennifer Altomonte, et al.

Pageof 7

Search research articles

Showing results (61-70 of 66) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 66 results.

Cancer Research|March 13, 2002

Treatment of ovarian cancer with a tropism modified oncolytic adenovirusGerd J Bauerschmitz, John T Lam, Anna Kanerva, et al.

Oncotarget|February 26, 2015

Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapyOtto Hemminki, Suvi Parviainen, Juuso Juhila, et al.

International Journal of Cancer|March 31, 2015

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humansSimona Bramante, Johanna K Kaufmann, Ville Veckman, et al.

Cancer Gene Therapy|March 16, 2004

Transcriptional targeting of tumors with a novel tumor-specific survivin promoterZeng B Zhu, Sharmila K Makhija, Baogen Lu, et al.

Human Gene Therapy|September 6, 2017

Virotherapy Research in Germany: From Engineering to TranslationGuy Ungerechts, Christine E Engeland, Christian J Buchholz, et al.

Viruses|August 28, 2021

Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical StudiesDirk M Nettelbeck, Mathias F Leber, Jennifer Altomonte, et al.

Pageof 7